Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas. - Sworder BJ; Kurtz DM; Alig SK; Frank MJ; Shukla N; Garofalo A; Macaulay CW; Shahrokh Esfahani M; Olsen MN; Hamilton J; Hosoya H; Hamilton M; et al. (Cancer cell, 2023)